<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04582188</url>
  </required_header>
  <id_info>
    <org_study_id>UHICU20201001</org_study_id>
    <nct_id>NCT04582188</nct_id>
  </id_info>
  <brief_title>The Early Coagulopathy for the Prognosis in Sepsis</brief_title>
  <official_title>An Observational Study on the Prognostic Function of Early Coagulopathy in Sepsis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuhan Union Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this cohort study, the parameters (TM, TAT, PIC, tPAIC, et al.) associated with the&#xD;
      hemostatic system will be collected in sepsis patients when admitted to the Intensive&#xD;
      Critical Unit. Parameters will be evaluated for their prognostic function of 28 days&#xD;
      mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The object of this study is to find the early mortality prognostic biomarkers within the&#xD;
      hemostatic system in sepsis patients. Blood samples will be collected from sepsis patients at&#xD;
      admission. Parameters reflect endothelial injury, such as thrombomodulin (TM), tissue type&#xD;
      plasminogen activator inhibitor complex (tPAIC), parameters reflect procoagulation condition,&#xD;
      such as thrombin-antithrombin complex (TAT), and parameters reflect hyperfibrinolysis, such&#xD;
      as plasmin-plasmin inhibitor complex (PIC) will be tested. Based on the results of these&#xD;
      parameters, sepsis patients will be divided into coagulation parameter normal or abnormal&#xD;
      groups. Twenty-eight days of mortality will be determined by patient follow-up. Regression&#xD;
      analysis will be used to evaluate the relationship between these parameters and the mortality&#xD;
      of sepsis patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 5, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Weeks</target_duration>
  <primary_outcome>
    <measure>28-day all course mortality</measure>
    <time_frame>28 days from ICU-admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>28 days from ICU-admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of using vasopressor</measure>
    <time_frame>28 days from ICU-admission</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sepsis</condition>
  <condition>Coagulopathy</condition>
  <condition>Outcome, Fatal</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All the patients diagnosed with sepsis in the ICU of Union Hospital, Tongji Medical&#xD;
        College, Huazhong University of Science and Technology.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted to ICU of Union Hospital, Tongji Medical College, Huazhong&#xD;
             University of Science and Technology from August 2020 to July 2022.&#xD;
&#xD;
          -  Patients diagnosed with sepsis. The criteria for diagnosis is: 1. Infection or&#xD;
             suspected infection; 2. SOFA score ≥ 2.&#xD;
&#xD;
          -  Age interval: 18 years -- 80 years.&#xD;
&#xD;
          -  Gender: unlimited.&#xD;
&#xD;
          -  Signed informed consent form received.&#xD;
&#xD;
          -  Results of the coagulation parameters tested within 24 hours after admission are&#xD;
             available.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant and lactating women.&#xD;
&#xD;
          -  With primary diseases that can cause thrombocytopenia or prolong prothrombin time,&#xD;
             such as leukemia.&#xD;
&#xD;
          -  Patients with severe liver dysfunction.&#xD;
&#xD;
          -  Patients with anticoagulation or fibrinolysis medications within 72 hours before&#xD;
             admission.&#xD;
&#xD;
          -  Patients are in a procoagulation condition, such as VTE patients, protein C or protein&#xD;
             S deficient individuals.&#xD;
&#xD;
          -  Patients with chronic renal failure.&#xD;
&#xD;
          -  Patients need ECMO therapy.&#xD;
&#xD;
          -  Patients with severe cardiopulmonary diseases or nervous system diseases.&#xD;
&#xD;
          -  Patients at the end-stage of disease.&#xD;
&#xD;
          -  Patients without signed informed consent forms.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Huaqing Shu, Dr.</last_name>
    <phone>‭13437284416</phone>
    <email>370247973@qq.com</email>
  </overall_contact>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 4, 2020</study_first_submitted>
  <study_first_submitted_qc>October 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wuhan Union Hospital, China</investigator_affiliation>
    <investigator_full_name>Hua-Qing Shu</investigator_full_name>
    <investigator_title>Associated Professor</investigator_title>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Thrombomodulin</keyword>
  <keyword>Thrombin-antithrombin complexe</keyword>
  <keyword>Plasmin-α2-plasmin inhibitor complex</keyword>
  <keyword>Tissue plasminogen activator-plasminogen activator inhibitor-1 complex</keyword>
  <keyword>Mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

